Cosmos Health Inc.: updates and filings

COSMNASDAQHealthcare · Wholesale-Drugs, Proprietaries & Druggists' Sundries

Price

$2.65

November 20, 2026

What Ploutos Investor adds for Cosmos Health

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 13 fiscal years, from 2013
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price has risen 1,286% since Aug 18, 2026, when the 10-Q these figures come from was filed ($0.21 then, $2.87 on Nov 19, 2026). The figures date from before that move.10-Q
  • The share price was recently adjusted for a split or a spin-off that the company's last filing does not include yet. Market value, P/E, yields and the other figures measured against the price would mix the new shares with the old figures, so we leave them out until the next filing.
  • The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Next results

in 56 daysAround Jan 15, 2027 · for Q4 2026

last Oct 22, 2026next Jan 15, 2027

An estimate from when it has reported before, and the timing has varied a little. The company announces the date itself.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Apr 15, 2026 latest annualAug 18, 2026 latest quarterly
  • Nov 16, 2026Notice that the quarterly report will be filed late
    FormNT 10-Q
  • Nov 12, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Nov 10, 2026Change to shareholders' rights, amended articles or bylaws (amendment)
    Form8-K/A
  • Nov 10, 2026Change to shareholders' rights, amended articles or bylaws
    Form8-K
  • Oct 30, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Oct 29, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Oct 22, 2026Results of operations, Regulation FD disclosure
    Form8-K
  • Oct 16, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Oct 9, 2026Results of operations
    Form8-K
  • Aug 20, 2026Results of operations
    Form8-K
  • Aug 18, 2026Quarterly reportfor the period to Jun 30, 2026
    Form10-Q
  • Aug 14, 2026Notice that the quarterly report will be filed late
    FormNT 10-Q
  • Jul 22, 2026Filing
    FormRW
  • Jul 17, 2026Shares registered for employees
    FormS-8
  • Jul 16, 2026Change to shareholders' rights, officer or director change, amended articles or bylaws, shareholder vote
    Form8-K
  • Jul 6, 2026Regulation FD disclosure, other material events
    Form8-K
  • Jun 8, 2026Shelf registration for future offerings (amendment)
    FormS-3/A
  • Jun 5, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Jun 5, 2026Additional annual meeting material
    FormDEFA14A
  • Jun 2, 2026Annual meeting proxy statement
    FormDEF 14A
  • May 22, 2026Preliminary proxy statement
    FormPRE 14A
  • May 22, 2026Results of operations
    Form8-K
  • May 20, 2026Quarterly reportfor the period to Mar 31, 2026
    Form10-Q
  • May 15, 2026Notice that the quarterly report will be filed late
    FormNT 10-Q
  • May 11, 2026Filing
    FormRW

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Oct 20, 2009.

The full analysis

What do Cosmos Health's filings show?

The filings are where every one of Cosmos Health's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.